EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

Clinical, Immunological, and Microbiological Aspects of Nontuberculous Mycobacterium (NTM)

Rina Diana Nurfitri, Fathiyah Isbaniah, Fariz Nurwidya, Rania Imaniar, Faiza Hatim, Ibrahim Nur Insan Putra Dharmawan

Jurnal Respirologi Indonesia · 31.01.2026 · 46 (1) · 59-72

DOI: 10.36497/jri.v46i1.1084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Respirologi Indonesia, online erschienen am 31.01.2026. Verfasst von Rina Diana Nurfitri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacteria (NTM) refer to all mycobacterial species except Mycobacterium tuberculosis (M. tuberculosis) complex and M. leprae complex. These bacteria are acid-fast. The bacteria are environmental bacteria that act opportunistically in humans. The infection can lead to disease, primarily affecting the lungs in susceptible hosts. Risk factors for NTM infection include defects in the body's defence mechanisms, changes in lung structure, and immune system abnormalities, which can be congenital or acquired. The bacteria possess pathogen-associated molecular patterns (PAMPs) and cell wall components that differ from those of M. tuberculosis, one of which is the glycopeptidolipid (GPL) component. Different species have distinct cell wall components, enabling them to modulate the immune system in various ways by interacting with multiple pathogen recognition receptors, including toll-like receptors and fibronectin. The cell-mediated immune response plays a role in the response to NTM infection. Alveolar macrophages, as the first line of defence, release interleukin (IL)-12, activating the T-helper-1 (Th1) axis and natural killer (NK) cells, followed by the release of tumour necrosis factor- α (TNF-α), interferon (IFN)-γ, and IL-17. The clinical symptoms of NTM lung disease (NTM-LD) are similar to those of M. tuberculosis. Two radiological findings are commonly observed: fibro-cavitary lesions and nodular bronchiectasis. Diagnosis must meet clinical, radiological, and microbiological criteria. The decision to start therapy should consider host factors, clinical conditions, and species type. The treatment approach involves multi-drug therapy and long-term administration, depending on species, disease extent, drug susceptibility testing results, and comorbidities.

Zitieren

APA

Nurfitri, R. D., Isbaniah, F., Nurwidya, F., Imaniar, R., Hatim, F., & Dharmawan, I. N. I. P. (2026). Clinical, Immunological, and Microbiological Aspects of Nontuberculous Mycobacterium (NTM). Jurnal Respirologi Indonesia, 46(1), 59-72. https://doi.org/10.36497/jri.v46i1.1084

Vancouver

Nurfitri RD, Isbaniah F, Nurwidya F, Imaniar R, Hatim F, Dharmawan INIP. Clinical, Immunological, and Microbiological Aspects of Nontuberculous Mycobacterium (NTM). Jurnal Respirologi Indonesia. 2026;46(1):59-72. doi:10.36497/jri.v46i1.1084

BibTeX
@article{Nurfitri2026,
  author = {Nurfitri, Rina Diana and Isbaniah, Fathiyah and Nurwidya, Fariz and Imaniar, Rania and Hatim, Faiza and Dharmawan, Ibrahim Nur Insan Putra},
  title = {Clinical, Immunological, and Microbiological Aspects of Nontuberculous Mycobacterium (NTM)},
  journal = {Jurnal Respirologi Indonesia},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {59--72},
  doi = {10.36497/jri.v46i1.1084}
}
Kostenlos starten →